Credit Suisse’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $318K | Sell |
|
|||||
|
2023
Q2 | $720K | Buy |
|
|||||
|
2023
Q1 | $1.15M | Buy |
|
|||||
|
2022
Q4 | $1.32M | Buy |
|
|||||
|
2022
Q3 | $1.44M | Buy |
|
|||||
|
2022
Q2 | $1.13M | Buy |
|
|||||
|
2022
Q1 | $1.52M | Sell |
|
|||||
|
2021
Q4 | $1.61M | Sell |
|
|||||
|
2021
Q3 | $1.27M | Sell |
|
|||||
|
2021
Q2 | $1.04M | Sell |
|
|||||
|
2021
Q1 | $1.23M | Sell |
|
|||||
|
2020
Q4 | $1.59M | Buy |
|
|||||
|
2020
Q3 | $1.6M | Buy |
|
|||||
|
2020
Q2 | $1.74M | Buy |
|
|||||
|
2020
Q1 | $734K | Sell |
|
|||||
|
2019
Q4 | $1.35M | Buy |
|
|||||
|
2019
Q3 | $1.18M | Sell |
|
|||||
|
2019
Q2 | $1.91M | Buy |
|
|||||
|
2019
Q1 | $2.05M | Sell |
|
|||||
|
2018
Q4 | $1.95M | Sell |
|
|||||
|
2018
Q3 | $2.72M | Buy |
|
|||||
|
2018
Q2 | $3.55M | Buy |
|
|||||
|
2018
Q1 | $2.33M | Buy |
|
|||||
|
2017
Q4 | $1.68M | Sell |
|
|||||
|
2017
Q3 | $1.5M | Buy |
|
|||||
|
2017
Q2 | $1.03M | Sell |
|
|||||
|
2017
Q1 | $1.43M | Buy |
|
|||||
|
2016
Q4 | $1.17M | Buy |
|
|||||
|
2016
Q3 | $744K | Buy |
|
|||||
|
2016
Q2 | $607K | Sell |
|
|||||
|
2016
Q1 | $995K | Buy |
|
|||||
|
2015
Q4 | $558K | Buy |
|
|||||
|
2015
Q3 | $581K | Sell |
|
|||||
|
2015
Q2 | $2.03M | Buy |
|
|||||
|
2015
Q1 | $929K | Buy |
|
|||||
|
2014
Q4 | $947K | Sell |
|
|||||
|
2014
Q3 | $755K | Buy |
|
|||||
|
2014
Q2 | $802K | Buy |
|
|||||
|
2014
Q1 | $424K | Buy |
|
|||||
|
2013
Q4 | $264K | Buy |
|